Dipartimento di Medicina Interna, Istituto di Medicina Interna e Terapia Medica, Facoltà di Medicina e Chirurgia, Università di Catania, Catania, Italy.
Endocr Res. 2012;37(2):47-58. doi: 10.3109/07435800.2011.625513. Epub 2011 Oct 18.
The renal resistive index (RRI) reflects intrarenal vascular resistance and stiffness, which are associated with chronic kidney disease. The links connecting renal function, intrarenal arterial resistance, and parathyroid hormone (PTH) with hypertension and metabolic factors remain elusive. The aim of this study is to investigate the possible relationship of RRI with glomerular filtration rate, PTH, hypertension, obesity (body mass index and waist-to-hip ratio), bioelectrical impedance analysis in body composition assessment, serum lipids, and insulin resistance assessed by homoeostasis model insulin resistance index.
This study was carried out on 387 (246 women, 141 men) nondiabetic patients, between >25 and <75 years, referred to an Internal Medicine Clinic and Day Hospital for essential hypertension, overweightness-obesity, and/or dyslipidemia. Lower salt/lower calorie Mediterranean diet, physical activity increase, smoking withdrawal, and lifestyle counseling, provided by a health psychologist support, were prescribed.
Higher hypertension risk, present in 42.5% of the overall group of eligible patients (164/387), is associated with high PTH and high RRI, along with greater renal insufficiency, insulin resistance, and obesity. There is a straight linear relationship of RRI to PTH (0.202; p=0.009) in arterial hypertension, which is not observed in normal blood pressure patients. By gender-adjusted multiple linear regression analysis, it was found that fat mass, waist-to-hip ratio, and PTH account significantly for 62.3% of the variance to RRI in hypertensive patients.
Increased arterial stiffness and intrarenal arterial resistance are associated with higher PTH in arterial hypertension; obesity (defined by greater fat mass and waist-to-hip ratio) and PTH are the independent conditions that account significantly for higher RRI.
肾阻力指数(RRI)反映了肾内血管阻力和硬度,与慢性肾脏病有关。肾功能、肾内动脉阻力和甲状旁腺激素(PTH)与高血压和代谢因素之间的联系仍不清楚。本研究旨在探讨 RRI 与肾小球滤过率、PTH、高血压、肥胖(体重指数和腰臀比)、生物电阻抗分析在身体成分评估中的关系、血脂以及通过稳态模型胰岛素抵抗指数评估的胰岛素抵抗之间的可能关系。
本研究纳入了 387 名(246 名女性,141 名男性)年龄在 25 岁至 75 岁之间的非糖尿病患者,他们因原发性高血压、超重肥胖和/或血脂异常被转介到内科诊所和日间医院。由健康心理学家提供低盐/低热量的地中海饮食、增加体力活动、戒烟和生活方式咨询等支持。
在符合条件的 387 名患者中,42.5%(164/387)的患者存在较高的高血压风险,与高 PTH 和高 RRI 相关,同时还存在更严重的肾功能不全、胰岛素抵抗和肥胖。在高血压患者中,RRI 与 PTH 呈直线正相关(0.202;p=0.009),但在血压正常的患者中则没有观察到这种关系。通过性别调整的多元线性回归分析,发现脂肪量、腰臀比和 PTH 显著解释了高血压患者 RRI 变化的 62.3%。
在动脉高血压中,动脉僵硬和肾内动脉阻力增加与较高的 PTH 相关;肥胖(定义为更大的脂肪量和腰臀比)和 PTH 是显著导致 RRI 增加的独立因素。